31
Chapter Four Psychopharmacology Version Dated 21 Sep 2009

Chapter Four Psychopharmacology Version Dated 21 Sep 2009

Embed Size (px)

Citation preview

Page 1: Chapter Four Psychopharmacology Version Dated 21 Sep 2009

Chapter Four

PsychopharmacologyVersion Dated 21 Sep 2009

Page 2: Chapter Four Psychopharmacology Version Dated 21 Sep 2009

CHAPTER 4PSYCHOPHARMACOLOGY

Page 3: Chapter Four Psychopharmacology Version Dated 21 Sep 2009

Neurotransmitters, Neuromodulators, and Neurohormones

• Identifying Neurotransmitters– Must be synthesized within the neuron– In response to an action potential, the substance is

released in sufficient quantities to produce an effect in the postsynaptic cell

– We should be able to duplicate the action of a suspected neurotransmitter experimentally on a postsynaptic cell

– Some mechanism exists that ends the interaction between the neurotransmitter and the postsynaptic cell

Page 4: Chapter Four Psychopharmacology Version Dated 21 Sep 2009

Figure 4.2 Major Categories of Neurotransmitters, Neuromodulators, and

Neurohormones

Page 5: Chapter Four Psychopharmacology Version Dated 21 Sep 2009

Neurotransmitters

• Types of Neurotransmitters– Small molecule transmitters – meet all or most of

criteria and play a vital role in neurotransmission– Neuropeptides – at least 40 act as

neurotransmitters, neuromodulators, and neurohormones

– Gaseous neurotransmitters – some gases transfer information from one cell to another

Page 6: Chapter Four Psychopharmacology Version Dated 21 Sep 2009

Table 4.1 Features of Small-Molecule Transmitters and Neuropeptides

Page 7: Chapter Four Psychopharmacology Version Dated 21 Sep 2009

Figure 4.3 The Distribution of Cholinergic Systems in the Brain

Page 8: Chapter Four Psychopharmacology Version Dated 21 Sep 2009

Figure 4.4 Catecholamines Share a Common Synthesis Pathway

Page 9: Chapter Four Psychopharmacology Version Dated 21 Sep 2009

Figure 4.5 Dopaminergic Systems in the Brain

Page 10: Chapter Four Psychopharmacology Version Dated 21 Sep 2009

Figure 4.6 Noradrenergic Systems in the Brain

Page 11: Chapter Four Psychopharmacology Version Dated 21 Sep 2009

Figure 4.8 The Distribution of Serotonergic Pathways in the Brain

Page 12: Chapter Four Psychopharmacology Version Dated 21 Sep 2009

Figure 4.9 The NMDA Glutamate Receptor

Page 13: Chapter Four Psychopharmacology Version Dated 21 Sep 2009

Figure 4.10 The GABAA Receptor Interacts with Several Drugs

Page 14: Chapter Four Psychopharmacology Version Dated 21 Sep 2009

Figure 4.11 Distribution of Opiate Receptors in the Human Brain

Page 15: Chapter Four Psychopharmacology Version Dated 21 Sep 2009

Drug Actions at the Synapse

• Agonists enhance the activity of a neurotransmitter• Antagonists reduce the activity of a neurotransmitter

Page 16: Chapter Four Psychopharmacology Version Dated 21 Sep 2009

Drug Actions at the Synapse

• Neurotransmitter Production– Manipulating the synthesis of a neurotransmitter will

affect the amount available for release

• Neurotransmitter Storage– Interfering with the storage of a neurotransmitters in

vesicles within a neuron

• Neurotransmitter Release– Drugs can modify the release of a neurotransmitter in

response to the arrival of an action potential

Page 17: Chapter Four Psychopharmacology Version Dated 21 Sep 2009

Drug Actions at the Synapse

• Receptor Effects– Can mimic the action of a neurotransmitter at the site– Can block the synaptic activity by occupying a binding site– Can influence the activity of the receptor

• Reuptake Effects and Enzymatic Degradation– Deactivation of neurotransmitters

Page 18: Chapter Four Psychopharmacology Version Dated 21 Sep 2009

Figure 4.12 Drug Interactions at the Cholinergic Synapse

Page 19: Chapter Four Psychopharmacology Version Dated 21 Sep 2009

Figure 4.14 Drug Interactions at the Dopaminergic Synapse

Page 20: Chapter Four Psychopharmacology Version Dated 21 Sep 2009

Figure 4.15 Drug Interactions at the Serotonergic Synapse

Page 21: Chapter Four Psychopharmacology Version Dated 21 Sep 2009

Basic Principles of Drug Effects

• Administration of Drugs– Method of administration leads to different effects on

nervous system– Blood-brain barrier

• Individual Differences– Drug effects influenced by body weight, gender, and

genetics

• Placebo Effects– User expectations influence drug effects– Double-blind experiment

Page 22: Chapter Four Psychopharmacology Version Dated 21 Sep 2009

Figure 4.16 Concentration of a Drug in the Blood Supply Depends on the Method of

Administration

Page 23: Chapter Four Psychopharmacology Version Dated 21 Sep 2009

Basic Principles of Drug Effects

• Tolerance and Withdrawal– Tolerance = lessened effects as a result of repeated

administration– Withdrawal = occurs when substance use is discontinued;

opposite of the effects caused by the discontinued drug

• Addiction– Compulsive need to use the drug repeatedly– Causes of addiction– Treatment of addiction

Page 24: Chapter Four Psychopharmacology Version Dated 21 Sep 2009

Figure 4.17 Tolerance and Withdrawal Can Result from Compensation

Page 25: Chapter Four Psychopharmacology Version Dated 21 Sep 2009

Figure 4.18 The Nucleus Accumbens Participates in Reward and Addiction

Page 26: Chapter Four Psychopharmacology Version Dated 21 Sep 2009

Effects of Psychoactive Drugs

• Stimulants – increase alertness and mobility– Caffeine – antagonist for adenosine– Nicotine – agonist at the nicotinic cholinergic receptor– Cocaine and Amphetamine

• Cocaine – dopamine reuptake inhibitor• Amphetamine – stimulates dopamine and norepinephrine release

and inhibits their reuptake

– Club Drugs: Ecstasy and GHB• MDMA – stimulates release of serotonin and oxytocin; toxic to

serotonergic neurons • GHB – mimics inhibitory effects of GABA

Page 27: Chapter Four Psychopharmacology Version Dated 21 Sep 2009

MDMA Ecstasy Destroys Serotonergic Neurons

Page 28: Chapter Four Psychopharmacology Version Dated 21 Sep 2009

Figure 4.20 Caffeine Content of Common Products

Page 29: Chapter Four Psychopharmacology Version Dated 21 Sep 2009

Effects of Psychoactive Drugs

• Opiates– Synthesized from sap of opium poppy– Morphine, codeine, heroin– Endorphin receptors

• Marijuana– THC – agonist at receptors for endogenous cannabinoids– Cannabinoid receptors in the hippocampus and prefrontal

cortex

Page 30: Chapter Four Psychopharmacology Version Dated 21 Sep 2009

Effects of Psychoactive Drugs

• Other hallucinogens – have the ability to produce false perceptions – Mushrooms – agonist for GABA and glutamate– Mescaline – acts on serotonergic neurons– Phencyclidine (PCP) – antagonist at the NMDA glutamate

receptor– LSD – serotonergic agonist

Page 31: Chapter Four Psychopharmacology Version Dated 21 Sep 2009

Effects of Psychoactive Drugs

• Alcohol– Agonist at the GABAA receptor

– Stimulates dopaminergic reward pathways– Damaging effects on health

• St. John’s Wort– Effective for mild depression– Interactions with other drugs